Vanda Pharmaceuticals Inc. (VNDA)

Market is closed

Insider Trading: Sales

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Dugan	$10.69	4,804	Director	5,770	2015-03-09	Filing
Watkins	$17.66	35,000	Director	0	2014-03-14	Filing
Repella	$12.12	64,100	Officer	15,000	2013-11-21	Filing
Repella	$11.89	40,515	Officer	21,490	2013-11-20	Filing
Repella	$12.07	2,885	Officer	21,490	2013-11-19	Filing
Polymeropoulos	$12.07	8,928	Officer, Director	471,636	2013-11-19	Filing
Kelly	$12.07	3,348	Officer	28,816	2013-11-19	Filing
Feeney	$4.65	4,760	Officer	11,942	2012-02-16	Filing
Polymeropoulos	$4.69	11,350	Officer, Director	428,650	2012-02-16	Filing
Kelly	$4.67	4,920	Officer	12,580	2012-02-16	Filing
Feeney	$4.65	4,760	Officer	14,927	2012-02-16	Filing
Feeney	$7.25	2,985	Officer	4,515	2011-02-18	Filing
Polymeropoulos	$8.10	82,600	Officer, Director	380,000	2010-12-10	Filing
Polymeropoulos	$8.11	17,400	Officer, Director	462,600	2010-12-09	Filing
Karabelas	$11.80	200,000	Director	0	2010-03-12	Filing
Ramsay	$11.80	200,000	Other	0	2010-03-12	Filing
Clark	$10.65	9,522	Officer	168,279	2010-02-19	Filing
Feeney	$10.56	20,000	Officer	0	2010-02-19	Filing
Irish	$10.59	20,000	Officer	2,249	2010-02-19	Filing
Tang	$10.73	54,900	Large Shareholder	2,715,852	2010-01-14	Filing